Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products.
administrat0rComments Off on J&J raises U.S. prices on around two dozen drugs 0
People who eat lots of high-fiber and whole grain foods have lower risk of heart disease, stroke, diabetes and other chronic diseases than people whose diets are low in fiber, a study commissioned by the World Health Organization (WHO) says.
administrat0rComments Off on Study details how high fiber diets make for healthier lives 0
(Reuters Health) – A year after giving birth, African-American mothers may have more signs of physical and mental stress that can raise the risk of chronic disease, compared with white or Latina women, a small U.S. study suggests.
administrat0rComments Off on Up to a year after pregnancy, race disparities in stress, recovery persist 0
(Reuters Health) – Spending on health care advertising in the U.S. has almost doubled over the past two decades as companies compete for their share of the world’s biggest health care market, a U.S. study suggests.
administrat0rComments Off on U.S. health care industry spends $30 billion a year on marketing 0